Découverte de la pénicilline, 2017. ,
Resistance to antibiotics: are we in the post-antibiotic era, Arch Med Res, vol.36, issue.6, pp.697-705, 2005. ,
Antimicrobial peptides of multicellular organisms, Nature, vol.415, pp.389-95, 2002. ,
In vitro activity of synthetic antimicrobial peptides against Candida, Pol J Microbiol, vol.55, pp.303-310 ,
, Des acides aminés synthétiques pour de nouveaux peptides
What will it take to address the global threat of antibiotic resistance?, J Law Med Ethics Boston Univ Sch, 2015. ,
Antimicrobial resistance: a global response, Bull World Health Organ, vol.80, issue.2, pp.126-159, 2002. ,
The emergence of antibiotic resistance by mutation, Clin Microbiol Infect, vol.13, issue.1, pp.5-18, 2007. ,
Antibiotic resistance-the need for global solutions, Lancet Infect Dis, vol.13, issue.12, pp.1057-1098, 2013. ,
Tackling Drug-Resistant Infections Globally: final report and recommendations. The review on microbial resistance, 2016. ,
Antimicrobial resistance : Global Report on Surveillance. WHO Library Cataloguing-in-Publication Data, 2014. ,
, , vol.316, pp.1193-204, 2016.
Special Eurobarometer Antimicrobial resistance, 2016. ,
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy, Antimicrob Agents Chemother, vol.54, issue.10, pp.4085-91, 2010. ,
WHO publishes list of bacteria for which new antibiotics are urgently needed, 2017. ,
Estimating the economic costs of antimicrobial resistance: Model and Results. RAND Corporation, 2014. ,
,
Indications for antibiotic use in ICU patients: a one-year prospective surveillance, Antimicrob Agents Chemother, vol.39, pp.527-562, 1997. ,
Antibiotic resistance in the intensive care unit, Ann Intern Med, vol.134, pp.298-314, 2001. ,
Antibiotic stewardship in the intensive care unit, Crit Care, vol.18, issue.5, p.480, 2014. ,
Seven ways to preserve the miracle of antibiotics, Clininical Infect Dis, vol.56, issue.10, pp.1445-50, 2013. ,
The Antibiotic Resistance Crisis. Part 1: Causes and Threats, Pharm Ther, vol.40, issue.4, pp.277-83, 2015. ,
, Best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem
, Antimicrobial resistance in human medicine
, European medecines agency, 2016.
FDA"s Take on the Executive Order and National Strategy to Combat Antibiotic-Resistant Bacteria, 2014. ,
Antimicrobial resistance in countries G7 Countries and beyond: Economic Issues, Policies and Options for Action, 2015. ,
, Un nouvel espoir de traitement des pneumonies graves
, Définition: Peptidomimétique. Le dictionnaire de l"Académie nationale de Pharmacie, 2015.
Antimicrobial peptide mimics for improved therapeutic properties, Biochim Biophys Acta, issue.8, pp.1582-92, 1788. ,
Cationic antimicrobial peptides: from innate immunity study to drug development. Update. Médecine Mal Infect, vol.37, pp.194-203, 2007. ,
The roles of antimicrobial peptides in innate host defense, Curr Pharm Des, vol.15, issue.21, pp.2377-92, 2009. ,
Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application, Peptides, vol.37, issue.2, pp.207-222, 2012. ,
The Roles of Antimicrobial Peptides in Innate Host Defense, Curr Pharm Des, vol.15, issue.21, pp.2377-92, 2009. ,
APD2: the updated antimicrobial peptide database and its application in peptide design, Nucleic Acids Res, vol.37, issue.1, pp.933-940, 2009. ,
LAMP: A Database Linking Antimicrobial Peptides, PLoS ONE, vol.8, issue.6, 2013. ,
, Antimicrobial Peptides. Pharmaceuticals, vol.6, issue.12, pp.1543-75
Fleming"s "Lysozyme, Calif West Med, vol.56, issue.1, p.5, 1942. ,
Treatment of War Wounds: A Historical Review, Clin Orthop Relat Res, vol.467, issue.8, pp.2168-91, 2009. ,
Plant defense peptides, Biopolymers, vol.47, pp.479-91, 1998. ,
, Defensins. Pharmacol Ther, vol.6, issue.4, pp.584-593, 1994.
Differential expression of alpha-and beta-defensins in human peripheral blood, Eur J Clin Invest, vol.33, pp.82-89, 2003. ,
Phylogenetic perspectives in innate immunity, Science, vol.284, issue.55418, pp.1313-1321, 1999. ,
Dictionnaire des Sciences pharmaceutiques et biologiques de l"Académie nationale de Pharmacie ,
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?, Nat Rev Microbiol, vol.3, issue.3, pp.238-50, 2005. ,
Peptide Antimicrobial Agents, Clin Microbiol Rev, vol.19, issue.3, pp.491-511, 2006. ,
Antimicrobial peptides : Discovery, design and novel therapeutic strategies, Trends Immunol, vol.30, issue.3, pp.131-172, 2009. ,
The relationship between peptide structure and antibacterial activity, Peptides, vol.24, issue.11, pp.1681-91 ,
The medicinal chemistry of peptides, Curr Med Chem, vol.16, issue.33, pp.4399-418, 2009. ,
The expanding scope of antimicrobial peptide structures and their modes of action, Trends Biotechnol, vol.29, issue.9, pp.464-72, 2011. ,
Mechanisms of antimicrobial peptide action and resistance, Pharmacol Rev, vol.55, issue.1, pp.27-55 ,
Mode of action of membrane active antimicrobial peptides, Biopolymers, vol.66, issue.4, pp.236-284, 2002. ,
Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides, Biochim Biophys Acta, vol.1462, issue.1-2, pp.55-70, 1999. ,
Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes, Biochim Biophys Acta, vol.1462, issue.1-2, pp.1-10, 1999. ,
Peptide therapeutics, current status and future directions, vol.20, pp.122-130, 2015. ,
Peptides and Peptidomimetics for antimicrobial drug design, Pharmaceuticals, vol.8, issue.3, pp.366-415, 2015. ,
Resistance to antimicrobial peptides in Gram-negative bacteria, FEMS Microb Lett, vol.330, issue.2, pp.81-90, 2012. ,
Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria, Antibiotics, vol.3, issue.4, pp.461-92, 2014. ,
Peptidomimetics, a synthetic tool of drug discovery, Curr Opin Chem Biol, vol.12, issue.3, pp.192-296, 2008. ,
Peptides and peptidomimetics in Medicinal Chemistry, 2012. ,
Peptidomimetics in Organic and Medicinal Chemistry, vol.308, 2014. ,
Peptidomimetics and their Applications in Antifungal Drug Design, Anti-Infect Agents Med Chem, vol.8, issue.4, pp.327-371 ,
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?, Int J Antimicrob Agents, vol.38, issue.3, p.21, 2011. ,
Investigational peptide and peptidomimetic ? and ? opioid receptor agonists in the relief of pain, Expert Opin Investig Drugs, vol.23, issue.2, 2014. ,
Peptidomimetics for drug design, vol.1, pp.663-685, 2003. ,
Polymer-Based Synthetic Mimics of Antimicrobial Peptides (SMAMPs)-A New Class of Nature-Inspired Antimicrobial Agents with Low Bacterial Resistance Formation Potential, Macromol Chem Phys, vol.10, 2014. ,
Pari gagné pour les peptides, vol.3157, 2009. ,
The emergence of peptides in the pharmaceutical business: From exploration to exploitation, EuPA Open Proteomics, vol.4, pp.58-69, 2014. ,
Folding amphipathic helices into membranes: amphiphilicity trumps hydrophobicity, J Mol Med Berl, vol.370, issue.3, pp.549-470, 2007. ,
EMA Annual Report, 2015. ,
EMA Annual report, 2016. ,
Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery, Nature, vol.354, issue.6348, pp.84-90, 1991. ,
Molecular recognition of protein-ligand complexes: applications to drug design, Chem Rev, vol.97, issue.5, pp.1359-472, 1997. ,
Recent advances in the design and synthesis of peptidomimetics, 2001. ,
Large-scale synthesis of peptides, Biopolymers, vol.55, issue.3, pp.227-50, 2000. ,
Peptides ad peptidomimetics as immunodulators, Immunotherapy, vol.6, issue.6, pp.755-74, 2014. ,
Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult of difficult sequences, Nat Protoc, vol.13, issue.12, pp.3247-56, 2007. ,
Synthesis of Novel Amino Acids and Peptidmimetics as Tools for Drug Discovery, 2013. ,
Methods, setup and safe handling for anhydrous hydrogen fluoride cleavage in Boc solid-phase peptide synthesis, Nat Protoc, vol.10, pp.1067-83, 2015. ,
Current drug research on PEGylation with small molecular agents, Prog Polym Sci, vol.38, issue.3-4, pp.421-465, 2013. ,
Effect of pegylation on pharmaceuticals, Nat Rev Drug Discov, vol.2, pp.214-235, 2003. ,
Antimicrobial peptides: an overview of a promising class of therapeutics, Cent Eur J Biol, vol.2, issue.1, pp.1-33, 2007. ,
Recent approaches in design of peptidomimetics for antimicrobal drug discovery research, Rev Med Chem, vol.13, issue.7, pp.1073-88 ,
Peptidomimetics-a versatile route to biologically active compounds, Eur J Org Chem, vol.30, issue.30, pp.5099-111, 2009. ,
Chirality, antimicrobial activity and proteolytic resistance, FEBS Lett, vol.274, issue.1-2, pp.151-156, 1990. ,
Evolution of Antimicrobial Peptides to Self-Assembled Peptides for Biomaterial Applications. Pathogens, vol.3, pp.791-821, 2014. ,
A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents, ChemMedChem, vol.7, issue.1, pp.114-136, 2012. ,
Substitution of the arginine/leucine residues in apidaecin ib with peptoid residues: Effect on antimicrobial activity, cellular uptake, and proteolytic degradation, J Med Chem, vol.52, issue.16, pp.5197-206, 2009. ,
Efficacy of oral etoposide in pretreated metastatic breast cancer: A multicenter phase 2 study. Medicine (Baltimore), vol.94, p.1, 2015. ,
Oligoarginine-PEG-lipid particles for gene delivery, Expert Opin Drug Deliv, vol.10, issue.10, pp.1065-77, 2009. ,
Nanotechnology advances in controlled drug delivery systems, Phys Status Sol C-Curr Top Solid State Phys, vol.5, issue.12, pp.3828-3861, 2008. ,
Peptidomimetics via modifications of amino acids and peptide bonds, Chem Soc Rev, vol.43, issue.10, pp.3575-94, 2014. ,
Peptidomimetics designed for oral absorption, Advanced in Amino Acid Mimetics and Peptidomimetics, pp.89-123, 1999. ,
Therapeutic application of peptides and proteins: parenteral forever?, Trends Biotechnol, vol.27, issue.11, pp.628-663, 2009. ,
Peptide formulation: challenges and strategies Payne, Innov Pharm Technol, p.4, 2009. ,
Peptide and protein PEGylation: a review of problems and solutions, Biomaterials, vol.22, pp.405-422, 2001. ,
Peptide PEGylation: The Next Generation. Pharm Technol, vol.11, 2011. ,
De la molécule aux tests finaux, tous les détails de sa conception ,
The future of peptide development in the pharmaceutical industry, PharManufacturing Int Pept Rev, pp.10-15, 2013. ,
Peptide therapeutics market: forecast and analysis 2015-2025, Oligos Pept-Chim Oggi-Chem Today, vol.34, issue.2, 2016. ,
, amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use, COMMISSION DIRECTIVE 2003/63/EC of 25, 2003.
, Assessment report for Bydureon, 2011.
Antimicrobial peptides stage a comeback, Nat Biotechnol, vol.31, issue.5, pp.379-82, 2013. ,
Peptidomimetics as a new generation of antimicrobial agents: current progress, Infect Drug Resist, vol.2014, issue.7, pp.229-266 ,
Human Antimicrobial Peptides and Proteins, Pharmaceuticals, vol.7, issue.5, pp.545-94, 42014. ,
Therapeutic importance of peptidomimetics in medicinal chemistry, J Chem Pharm Res, vol.3, issue.6, pp.173-86, 2011. ,
De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications, Acc Chem Res, vol.43, issue.1, pp.30-39, 2010. ,
Nisin, alone and combined with peptidoglycan-modulating antibiotics: Activity against methicillin-resistant ,
, Staphylococcus aureus and vancomycin-resistant enterococci, J Antimicrob Chemother, vol.50, pp.731-734, 2002.
Mammalian defensins in immunity: more than just microbicidal, Trends Immunol, vol.23, pp.291-297, 2002. ,
A la decouverte des peptides antimicrobiens ,
, Universite Henri Poincare-Nancy 1, 2010.
Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor, Proc Natl Acad Sci, vol.84, pp.5449-5453, 1987. ,
Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis, Antimicrob Agents Chemother, vol.48, pp.641-643, 2004. ,
Antinematodal effect of antimicrobial peptide, p.23 ,
, J Pept Sci, vol.10, pp.304-311
From antimicrobial to anticancer peptides. A review. Front Microbiol, vol.4, pp.1-16, 2013. ,
The Use of Therapeutic Peptides to Target and to Kill Cancer Cells, Curr Med Chem, vol.19, issue.22, pp.3794-3804, 2012. ,
Le virus de l"immunodéficience humaine, 2005. ,
Chemical Stability of New Acyclovir Analogues with Peptidomimetics, Sci Pharm, vol.79, issue.2, pp.259-64, 2010. ,
Design of small peptidomimetic HIV-1 protease inhibitors and prodrug forms, Lett Pept Sci, vol.6, issue.5, pp.275-81, 1999. ,
Advancements in the field of Synthetic Peptides and emergence of prominent biopharmaceutical companies are fuelling the growth: Global Industry Analysis and Opportunity Assessment, Future Mark Insights, vol.172, pp.2015-2025, 2016. ,
The future of peptide-based drugs, Chem Biol Drug Des, vol.81, issue.1, pp.136-183, 2013. ,
Multifunctional antimicrobial peptides: therapeutic targets in several human diseases, J Mol Med Berl, vol.85, issue.4, pp.317-346, 2007. ,
Beyond natural antimicrobial peptides : multimeric peptides and other peptidomimetic approaches, Cell Mol Life Sci, vol.68, issue.13, pp.2255-66, 2011. ,
Peptidomimetic therapeutics: scientific approaches and opportunities, Drug Discov Today, vol.0, issue.0, pp.1-9, 2016. ,
Le business model cassé des antibiotiques. Le monde, 2004. ,